Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis ; volume:15 ; number:1 ; day:13 ; month:11 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (13.11.2024), 1-18, 12.2024
- Creator
-
Wang, XinYue
Jowsey, William J.
Cheung, Chen-Yi
Smart, Caitlan J.
Klaus, Hannah R.
Seeto, Noon EJ
Waller, Natalie JE
Chrisp, Michael T.
Peterson, Amanda L.
Ofori-Anyinam, Boatema
Strong, Emily
Nijagal, Brunda
West, Nicholas P.
Yang, Jason H.
Fineran, Peter C.
Cook, Gregory M.
Jackson, Simon A.
McNeil, Matthew B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-54072-w
- URN
-
urn:nbn:de:101:1-2501292149143.234931674725
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, XinYue
- Jowsey, William J.
- Cheung, Chen-Yi
- Smart, Caitlan J.
- Klaus, Hannah R.
- Seeto, Noon EJ
- Waller, Natalie JE
- Chrisp, Michael T.
- Peterson, Amanda L.
- Ofori-Anyinam, Boatema
- Strong, Emily
- Nijagal, Brunda
- West, Nicholas P.
- Yang, Jason H.
- Fineran, Peter C.
- Cook, Gregory M.
- Jackson, Simon A.
- McNeil, Matthew B.
- SpringerLink (Online service)
Other Objects (12)
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Novel mutations in katG gene of a clinical isolate of isoniazid-resistant Mycobacterium tuberculosis
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Novel mutations in katG gene of a clinical isolate of isoniazid-resistant Mycobacterium tuberculosis
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates